|
|
|
|
|
|
|
|
|
|
Akt-activated endothelium constitute the niche for residual disease and resistance to bevacizumab in ovarian cancer
Conclusion: Our data highlights the role of an activated
endothelium in the constitution of the residual disease and resistance
to bevacizumab. These results hint on the concept of using combination
therapy to override drug resistance in ovarian cancer and to suppress or
eradicate residual disease.
Read More:
Read More:
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.